ZYNE - Zynerba Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts8588
Avg. Estimate-0.6-0.69-2.5-2.69
Low Estimate-0.66-1.12-2.71-4.24
High Estimate-0.5-0.45-2.4-2.06
Year Ago EPS-0.7-0.6-2.57-2.5
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts8488
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/A7kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.-0.75-0.55-0.6-0.59
EPS Actual-0.7-0.6-0.64-0.63
Difference0.05-0.05-0.04-0.04
Surprise %6.70%-9.10%-6.70%-6.80%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate-0.6-0.69-2.5-2.69
7 Days Ago-0.61-0.75-2.52-2.68
30 Days Ago-0.61-0.75-2.53-2.76
60 Days Ago-0.61-0.75-2.53-2.76
90 Days Ago-0.58-0.64-2.42-2.39
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesZYNEIndustrySectorS&P 500
Current Qtr.14.30%N/AN/A0.34
Next Qtr.-15.00%N/AN/A0.40
Current Year2.70%N/AN/A0.17
Next Year-7.60%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A